March 21, 2011

Generic drug maker Mylan is suing the Food and Drug Administration in an effort to prevent Gurgaon, India-based competitor Ranbaxy Labs from launching its generic version of Pfizer’s cholesterol medication Lipitor, according to published reports.

March 15, 2011

Five senators have issued a letter to Food and Drug Administration commissioner Margaret Hamburg to expand Americans' access to affordable medications by avoiding the delay of generic drug approvals.

February 18, 2011

A whole slew of drugs will lose patent protection this year, opening up opportunities for generic drug makers to market their own versions. Most notable among these is Pfizer’s cholesterol-
lowering drug Lipitor (atorvastatin), the world’s top-selling drug, with U.S. sales of $7 billion during the 12 months ended September 2010, according to IMS Health.


February 18, 2011

A drug used to treat high cholesterol, which will lose patent protection and face generic competition starting this year, also may help prevent blindness in people with diabetes, according to a study by researchers at the University of Georgia.

February 10, 2011

This year’s upcoming $29 billion wave of margin-friendly generic pharmaceuticals will be as big a growth catalyst for supermarket pharmacies as it will be for their pureplay drug store cousins, Credit Suisse research analyst Ed Kelly stated in a note published Thursday.

February 4, 2011

The cardiovascular drug market will turn into a difficult conquest in the years to come as it increasingly will be dominated by generics, but that isn’t stopping drug companies from continuing to develop treatments — 299 of them, according to a recent report by the Pharmaceutical Research and Manufacturers of America — for high cholesterol, hypertension, atrial fibrillation, heart failure and other heart-related conditions.

February 1, 2011

NEW YORK — The U.S. healthcare system could get at least $70 billion in savings over the next four years thanks to loss of patent protection for branded drugs, according to published reports.


IMS Health SVP Murray Aitken said at the Reuters Health Summit that generics also would increase their dominance in terms of prescriptions dispensed, increasing from 77% during the first half of this year to perhaps 85% by 2014, Reuters reported.


January 25, 2011

Generic drug maker Mylan has entered settlements with Pfizer concerning two drugs for treating cholesterol.

January 21, 2011

Generic drug maker Watson Pharmaceuticals expects sales of $4.2 billion for 2011, the company said Friday.

January 19, 2011

In response to articles that appeared in several media outlets about its generic drug pipeline, drug maker Impax Labs is looking to set the record straight.

January 5, 2011

A generic version of the world’s top-selling cholesterol treatment is expected to hit the market this year, but the branded version’s manufacturer is trying to put the brakes on the launch, according to media reports.

December 21, 2010

Pfizer on Monday announced that it intends to recall one lot — approximately 19,000 bottles — of Lipitor 40-mg tablets (atorvastatin calcium) distributed in the United States because of one customer’s report of an uncharacteristic odor related to the bottles in which these lots of Lipitor were packaged.

November 14, 2010

The world of generic drugs has a big year ahead of it. Actually, it has...

November 8, 2010

Loss of patent protection for branded drugs and subsequent competition from generics could save the...

August 30, 2010

The U.S. drug market will present opportunities as well as uncertainties over the next decade,...

July 6, 2010

Changing generic substitution laws in favor of less-restrictive regulations could save states struggling to pay...

June 20, 2010

A new cholesterol drug made by Eli Lilly and Kowa Pharmaceuticals America has become available,...

June 14, 2010

The growth rate for employers’ medical costs is expected to fall somewhat next year, according...

May 19, 2010

A subsidiary of generic drug maker Watson Pharmaceuticals has launched a version of a cholesterol-lowering...

March 8, 2010

An organization representing the generic drug industry is hoping that Congress gives the Food and...

March 2, 2010

It appears that Pfizer has changed its mind a second time about buying Ratiopharm....

February 28, 2010

GlaxoSmithKline has identified more than 5,500 rare diseases it potentially could target as part of...

February 7, 2010

Patent expiries on blockbuster branded drugs could mean huge profits for some retail pharmacy chains,...

October 18, 2009

What’s really intriguing behind the return of a consumer division to Pfizer is the fact...